Affinage

SPRR1A

Cornifin-A · UniProt P35321

Length
89 aa
Mass
9.9 kDa
Annotated
2026-04-28
11 papers in source corpus 5 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

SPRR1A is a small proline-rich protein that functions as a regeneration-associated and differentiation-linked effector promoting cell adhesion, proliferation, and migration in multiple tissue contexts. In keratinocytes, SPRR1A transcription is driven by a compact 173-bp proximal promoter requiring cooperative AP-1 and Ets (ESE-1) elements activated downstream of calcium and PKC signaling (PMID:9733767). In injured peripheral neurons, Sox11 directly binds the Sprr1a promoter to activate transcription required for axon regeneration, and post-transcriptional repression by miR-463-3p limits SPRR1A-dependent neurite outgrowth (PMID:22024412, PMID:31468997). In the heart, miR-150 represses SPRR1A in cardiomyocytes and cardiac fibroblasts, and genetic epistasis demonstrates that SPRR1A mediates profibrotic remodeling after myocardial infarction (PMID:37468478).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 1998 High

    Defining the cis-regulatory logic of SPRR1A transcription in keratinocytes revealed that a minimal 173-bp promoter integrates calcium and PKC signals through cooperative AP-1 and Ets (ESE-1) binding sites, establishing SPRR1A as a direct transcriptional target of differentiation-linked signaling.

    Evidence Promoter deletion/mutation, reporter assays, EMSA, and binding-site swapping in primary keratinocytes stimulated with calcium or TPA

    PMID:9733767

    Open questions at the time
    • Identity of the specific AP-1 heterodimer(s) responsible in vivo not determined
    • Contribution of chromatin remodeling or distal enhancers not addressed
    • Whether similar promoter logic operates in non-keratinocyte contexts unknown
  2. 2011 High

    Demonstrating that Sox11 directly binds and transactivates the Sprr1a promoter in adult DRG neurons, and that this is required for Sox11-driven nerve regeneration, established SPRR1A as a functionally essential regeneration-associated gene downstream of an injury-induced transcription factor.

    Evidence ChIP, promoter mutagenesis, HSV-mediated Sox11 overexpression in DRG neurons, and in vivo saphenous nerve crush model

    PMID:22024412

    Open questions at the time
    • Mechanism by which SPRR1A protein promotes axon elongation is unknown
    • Whether Sox11 and SPRR1A operate in central nervous system regeneration not tested
    • Relationship between Sox11 and the AP-1/Ets pathway in neurons not explored
  3. 2019 Medium

    Identification of miR-463-3p as a post-transcriptional repressor of SPRR1A in tibial nerve cells showed that SPRR1A levels are tuned by microRNA regulation and that derepression enhances neurite outgrowth and nerve regeneration in vivo.

    Evidence Gain- and loss-of-function of miR-463-3p in primary tibial nerve cells and in vivo tibial nerve crush model

    PMID:31468997

    Open questions at the time
    • Direct 3′-UTR luciferase reporter validation of the miR-463-3p binding site was not explicitly shown
    • Whether miR-463-3p regulation of SPRR1A operates in DRG or central neurons not assessed
    • Downstream effectors of SPRR1A in neurite outgrowth remain uncharacterized
  4. 2023 High

    Genetic epistasis in miR-150 knockout × Sprr1a-hypomorphic mice demonstrated that SPRR1A mediates adverse profibrotic cardiac remodeling after myocardial infarction, expanding its functional role beyond epithelial differentiation and nerve regeneration into pathological fibrosis.

    Evidence Double-mutant mouse model post-MI, human cardiac fibroblast hypoxia/reoxygenation culture, carvedilol treatment, and cardiac function/fibrosis readouts

    PMID:37468478

    Open questions at the time
    • Molecular mechanism by which SPRR1A promotes fibrosis (direct binding partners or signaling pathway in fibroblasts) is unknown
    • Whether SPRR1A acts cell-autonomously in cardiomyocytes versus fibroblasts not resolved
    • Relevance to human heart failure beyond the mouse model not established
  5. 2024 Medium

    SPRR1A knockdown in osteosarcoma stem-like cells reduced proliferation, migration, and tumorigenicity with transcriptomic evidence of suppressed cell adhesion programs, placing SPRR1A as a cell adhesion-related promoter of tumor progression.

    Evidence siRNA knockdown in MG-OKS cells, proliferation/migration assays, RNA-seq, and in vivo nude mouse tumor transplantation

    PMID:39704263

    Open questions at the time
    • Single laboratory study; independent replication in additional osteosarcoma models needed
    • Direct protein interaction partners mediating cell adhesion effects are unidentified
    • Whether SPRR1A's pro-tumorigenic role extends to other cancer types is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • The biochemical mechanism of action of SPRR1A protein — its direct binding partners, structural role in the cell envelope or cytoskeleton, and how a small proline-rich protein promotes adhesion, migration, and regeneration across such diverse tissues — remains undefined.
  • No crystal or cryo-EM structure of SPRR1A or its complexes exists
  • Direct protein-protein interaction partners have not been identified by unbiased methods
  • No reconstituted biochemical activity has been demonstrated for SPRR1A

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098631 cell adhesion mediator activity 1
Pathway
R-HSA-1500931 Cell-Cell communication 1
Partners

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1998 The 173-bp proximal promoter of SPRR1A is necessary and sufficient for regulated expression in primary keratinocytes; calcium-induced expression requires both an AP-1 and an Ets binding site, while TPA/PKC signaling acts primarily through the Ets element. The ESE-1 Ets transcription factor is induced by TPA with kinetics similar to SPRR1A, and binding site swapping revealed that flanking nucleotides and global promoter context determine AP-1 contribution. Promoter deletion/mutational analysis, binding site swapping, reporter assays, gel-shift assays in primary keratinocytes stimulated with calcium or TPA The Journal of biological chemistry High 9733767
2011 Sox11 transcriptionally activates Sprr1a in adult peripheral neurons, and this activation is required for Sox11-mediated nerve regeneration; Sox11 binds the Sprr1a promoter (shown by chromatin immunoprecipitation), and mutation of the Sox11 binding site abolishes transactivation and the regenerative phenotype. HSV-vector-mediated Sox11 overexpression in DRG neurons, chromatin immunoprecipitation (ChIP) assay, promoter mutational analysis, in vivo saphenous nerve crush model, neurite elongation assay Experimental neurology High 22024412
2019 miR-463-3p directly targets SPRR1A mRNA and post-transcriptionally suppresses its expression, thereby inhibiting neurite outgrowth, percentage of cells with neurites, and cell branching in tibial nerve cells; inhibition of miR-463-3p increases SPRR1A expression and improves tibial nerve regeneration in vivo. Gain- and loss-of-function of miR-463-3p in primary tibial nerve cells, bioinformatics target prediction, in vivo tibial nerve crush model with miR-463-3p modulation and SPRR1A expression measurement Artificial cells, nanomedicine, and biotechnology Medium 31468997
2023 SPRR1A is a direct downstream target of miR-150 in cardiomyocytes and cardiac fibroblasts; miR-150 represses SPRR1A expression, and Sprr1a knockdown in a miR-150 knockout mouse rescues adverse post-MI cardiac remodeling (dysfunction and fibrosis). In human cardiac fibroblasts, hypoxia/reoxygenation upregulates SPRR1A, carvedilol downregulates it inversely to miR-150, and the protective effects of miR-150 are mediated through functional repression of profibrotic SPRR1A. miR-150 knockout combined with Sprr1a-hypomorphic mouse model (double-mutant epistasis), human cardiac fibroblast culture under hypoxia/reoxygenation, carvedilol treatment, cardiac function and fibrosis readouts post-MI Cell death & disease High 37468478
2024 SPRR1A knockdown (siRNA) in osteosarcoma cancer stem cell-like cells (MG-OKS) reduces cell proliferation, migration, and in vivo tumorigenicity, with RNA sequencing revealing suppression of cell adhesion genes, indicating SPRR1A functions as a cell adhesion-related molecule promoting osteosarcoma progression. siRNA knockdown, cell proliferation and migration assays, RNA sequencing, in vivo subcutaneous tumor transplantation in nude mice Oncology reports Medium 39704263

Source papers

Stage 0 corpus · 11 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2011 The transcription factor Sox11 promotes nerve regeneration through activation of the regeneration-associated gene Sprr1a. Experimental neurology 73 22024412
1998 AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker. The Journal of biological chemistry 72 9733767
2009 Expression of the regeneration-associated protein SPRR1A in primary sensory neurons and spinal cord of the adult mouse following peripheral and central injury. The Journal of comparative neurology 62 19107756
2006 Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat. Experimental neurology 43 16321384
2022 Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients. BMC cancer 15 35768785
2023 SPRR1A is a key downstream effector of MiR-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation. Cell death & disease 14 37468478
2014 Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: a prospective, observational study. BMC cancer 12 24886019
2019 The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes. Head & neck 11 30652380
2014 Clinical significance of SPRR1A expression in progesterone receptor-positive breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 11 25424702
2019 MiR-463-3p inhibits tibial nerve regeneration via post-transcriptional suppression of SPRR1A. Artificial cells, nanomedicine, and biotechnology 4 31468997
2024 SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncology reports 2 39704263